Fund
BDC Life Sciences Venture Fund
BDC Life Sciences Venture Fund took part in the round of Specific Biologics (35 M$, Series A) on 2 November 2026. It is the only health round Bolus has logged for it so far.
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
Get BDC Life Sciences Venture Fund's next deals
An email each time this fund appears in a new health deal, plus the Friday newsletter. Nothing else.
Free. One click to unsubscribe. The list is never sold. In French.
- Operations logged
- 1
- Lead
- 0
- New entries
- 1
- Follow ons
- 0
- Latest operation
- 2 November 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 02 Nov | Canada, Biotech | Series A | 35 M$ | Participant |
Co investors 6 funds crossed
- adMare BioInnovations 1 operation
- DeepWork Capital 1 operation
- Genesys Capital 1 operation
- Hatteras Venture Partners 1 operation
- Lumira Ventures 1 operation
- Seido Capital 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: Canada.